ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
58.22
+1.56 (2.75%)
Sep 18, 2025, 1:40 PM EDT - Market open
BIB Holdings Information
BIB is an equity ETF with a total of 261 individual holdings. The top holdings are NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG stock at 31.74%, NASDAQ BIO INDEX SWAP BNP PARIBAS at 25.97%, NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA at 24.77%, NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA at 20.70%, and NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE at 16.62%.
Total Holdings
261
Top 10 Percentage
152.83%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
54.86M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 31.74% |
2 | n/a | NASDAQ BIO INDEX SWAP BNP PARIBAS | 25.97% |
3 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 24.77% |
4 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 20.70% |
5 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 16.62% |
6 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 16.58% |
7 | GILD | Gilead Sciences, Inc. | 4.46% |
8 | AMGN | Amgen Inc. | 4.20% |
9 | VRTX | Vertex Pharmaceuticals Incorporated | 3.92% |
10 | REGN | Regeneron Pharmaceuticals, Inc. | 3.87% |
11 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.36% |
12 | AZN | AstraZeneca PLC | 2.93% |
13 | INSM | Insmed Incorporated | 1.69% |
14 | ARGX | argenx SE | 1.52% |
15 | BIIB | Biogen Inc. | 1.35% |
16 | UTHR | United Therapeutics Corporation | 1.15% |
17 | INCY | Incyte Corporation | 1.04% |
18 | ILMN | Illumina, Inc. | 1.03% |
19 | RPRX | Royalty Pharma plc | 0.96% |
20 | TEM | Tempus AI, Inc. | 0.94% |
21 | MEDP | Medpace Holdings, Inc. | 0.90% |
22 | NBIX | Neurocrine Biosciences, Inc. | 0.89% |
23 | ONC | BeOne Medicines AG | 0.87% |
24 | SMMT | Summit Therapeutics Inc. | 0.86% |
25 | SNY | Sanofi | 0.84% |
As of Sep 16, 2025